Literature DB >> 27651142

Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Fritz C Roller1, Christoph Wiedenroth2, Andreas Breithecker3, Christoph Liebetrau4, Eckhard Mayer2, Christian Schneider3, Andreas Rolf4, Christian Hamm4,5, Gabriele A Krombach3.   

Abstract

OBJECTIVES: The aim of this study was to assess septal and right ventricular insertion point (RVIP) fibrosis in patients with chronic thromboembolic pulmonary hypertension (CTEPH) via native T1 mapping and extracellular volume fraction (ECV) determination and to analyze correlations with functional parameters.
METHODS: Imaging was performed at 1.5 Tesla in 24 patients diagnosed with CTEPH and 24 controls. T1 values were measured within the septal myocardium, the upper and lower RVIP, and the lateral wall at basal short axis section.
RESULTS: The mean septal native T1 values were 1012.8 ms ± 50.5 in the CTEPH group and 956.9 ms ± 24.4 in controls (p < 0.001), upper RIVP 1050.8 ms ± 64.2 vs. 965.3 ms ± 37.1 (p < 0.001), and lower RVIP 1084.4 ms ± 93.1 vs. 959.8 ms ± 40.4 (p < 0.001). The corresponding mean ECV values were also significantly increased in the CTEPH group (p < 0.001). Native septal T1 showed a strong negative correlation with right ventricular ejection fraction (k = -0.92; p = 0.01).
CONCLUSIONS: We conclude that native T1 mapping and ECV assessment enable visualization and quantification of septal fibrosis in CTEPH patients. The results also correlate well with right ventricular ejection fraction. Therefore, these parameters might be useful for prognosis and as therapy-monitoring tool in the future. KEY POINTS: • Septal native T1 and ECV values are significantly higher in CTEPH patients. • Native T1 and ECV values are elevated even in absence of LGE. • These techniques therefore enable an improved quantification of septal fibrosis in CTEPH. • Native T1 values also correlate well with right ventricular EF and PA-pressure. • Prognosis and therapy-monitoring might be assessable in the future with these parameters.

Entities:  

Keywords:  CTEPH; ECV; MRI; PH; T1 Mapping

Mesh:

Year:  2016        PMID: 27651142     DOI: 10.1007/s00330-016-4585-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension.

Authors:  Javier Sanz; Santo Dellegrottaglie; Mbabazi Kariisa; Roxana Sulica; Michael Poon; Thomas P O'Donnell; Davendra Mehta; Valentin Fuster; Sanjay Rajagopalan
Journal:  Am J Cardiol       Date:  2007-06-27       Impact factor: 2.778

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.

Authors:  Joanna Pepke-Zaba; Marion Delcroix; Irene Lang; Eckhard Mayer; Pavel Jansa; David Ambroz; Carmen Treacy; Andrea M D'Armini; Marco Morsolini; Repke Snijder; Paul Bresser; Adam Torbicki; Bent Kristensen; Jerzy Lewczuk; Iveta Simkova; Joan A Barberà; Marc de Perrot; Marius M Hoeper; Sean Gaine; Rudolf Speich; Miguel A Gomez-Sanchez; Gabor Kovacs; Abdul Monem Hamid; Xavier Jaïs; Gérald Simonneau
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

5.  Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism.

Authors:  Thomas M Berghaus; Maria Barac; Wolfgang von Scheidt; Martin Schwaiblmair
Journal:  Thromb Res       Date:  2011-08-17       Impact factor: 3.944

6.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

7.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Raffaele Pesavento; Mauro Silingardi; Renzo Poggio; Maria Rita Taliani; Walter Ageno
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

Review 8.  State of the Art: Clinical Applications of Cardiac T1 Mapping.

Authors:  Erik B Schelbert; Daniel R Messroghli
Journal:  Radiology       Date:  2016-03       Impact factor: 11.105

9.  Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings.

Authors:  Steve Bandula; Steven K White; Andrew S Flett; David Lawrence; Francesca Pugliese; Michael T Ashworth; Shonit Punwani; Stuart A Taylor; James C Moon
Journal:  Radiology       Date:  2013-07-22       Impact factor: 11.105

10.  Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.

Authors:  Peter Kellman; Joel R Wilson; Hui Xue; W Patricia Bandettini; Sujata M Shanbhag; Kirk M Druey; Martin Ugander; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-11       Impact factor: 5.364

View more
  14 in total

1.  Association of native T1 times with biventricular function and hemodynamics in precapillary pulmonary hypertension.

Authors:  Yin Yin Chen; Hong Yun; Hang Jin; De Hong Kong; Yu Liang Long; Cai Xia Fu; Shan Yang; Meng Su Zeng
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-17       Impact factor: 2.357

2.  Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Authors:  F C Roller; S Kriechbaum; A Breithecker; C Liebetrau; M Haas; C Schneider; A Rolf; S Guth; E Mayer; C Hamm; G A Krombach; C B Wiedenroth
Journal:  Eur Radiol       Date:  2018-08-29       Impact factor: 5.315

Review 3.  Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.

Authors:  Fawaz Alenezi; Taylor A Covington; Monica Mukherjee; Stephen C Mathai; Paul B Yu; Sudarshan Rajagopal
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

4.  Right ventricular septomarginal trabeculation hypertrophy is associated with disease severity in patients with pulmonary arterial hypertension.

Authors:  Yang Dong; Jiayu Sun; Dan Yang; Juan He; Wei Cheng; Ke Wan; Hong Liu; Andreas Greiser; Xiaoyue Zhou; Yuchi Han; Yucheng Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-31       Impact factor: 2.357

5.  Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension.

Authors:  Catherine E Simpson; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 6.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

Review 7.  Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction.

Authors:  Pankaj Garg; Laura C Saunders; Andrew J Swift; Jim M Wild; Sven Plein
Journal:  Anatol J Cardiol       Date:  2018-04-10       Impact factor: 1.596

Review 8.  Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

Authors:  Barbro Kjellström; Anthony Lindholm; Ellen Ostenfeld
Journal:  Curr Heart Fail Rep       Date:  2020-10

9.  Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.

Authors:  Laura C Saunders; Chris S Johns; Neil J Stewart; Charlotte J E Oram; David A Capener; Valentina O Puntmann; Charlie A Elliot; Robin C Condliffe; David G Kiely; Martin J Graves; Jim M Wild; Andy J Swift
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-03       Impact factor: 5.364

10.  Application and Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio in Patients with Ischemic and Non-Ischemic Cardiomyopathy.

Authors:  Stanislav Keranov; Saskia Haen; Julia Vietheer; Wiebke Rutsatz; Jan-Sebastian Wolter; Steffen D Kriechbaum; Beatrice von Jeinsen; Pascal Bauer; Khodr Tello; Manuel Richter; Oliver Dörr; Andreas J Rieth; Holger Nef; Christian W Hamm; Christoph Liebetrau; Andreas Rolf; Till Keller
Journal:  Diagnostics (Basel)       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.